Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

SHARE-BASED COMPENSATION (Tables)

v3.25.4
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
 
Year ended December 31,
 
2025
 
2024
 
2023
           
Expected term, in years
4.57
 
4.57
 
4.59
Expected volatility
67%
 
69%
 
67%
Risk-free interest rate
3.74%-4.10%
 
3.72%-4.40%
 
4.30%-4.55%
Expected dividend yield
0%
 
0%
 
0%
Summary of Share-Based Compensation Arrangements by Share-based Payment Award
   
Number of options
   
Weighted-average exercise price
   
Weighted- average remaining contractual term (in years)
   
Aggregate intrinsic value
 
                         
Outstanding at January 1, 2025
   
10,857,287
   
$
4.76
     
4.20
   
$
4,343
 
                                 
Granted
   
550,016
   
$
1.55
                 
Exercised
   
1,094,849
   
$
0.73
           
$
705
 
Forfeited
   
120,716
   
$
3.66
                 
Expired
   
646,042
   
$
5.1
                 
                                 
Outstanding at December 31, 2025
   
9,545,696
   
$
5.03
     
3.36
   
$
539
 
                                 
Exercisable at December 31, 2025
   
8,496,180
   
$
5.41
     
3.06
   
$
507
 
Summary of Restricted Stock Units granted
   
Number of shares
   
Weighted average grant date fair value per share
 
             
Unvested as of January 1, 2025
   
16,859,323
   
$
2.15
 
Granted
   
17,509,288
   
$
1.27
 
Vested
   
5,569,484
   
$
2.24
 
Forfeited
   
3,374,691
   
$
2.99
 
Unvested as of December 31, 2025
   
25,424,436
   
$
1.41
 
Summary of Share Based Payment Award Equity Instruments Other Than Options Valuation Assumptions
 
Year ended December, 31,2025
      
Share price
$
1.20
Expected volatility
  86.61%
Risk-free interest rate
  3.69%
Expected dividend yield
  0%
Expected term (years)
  2.67-2.98
Summary of Share-Based Payment Arrangement, Expensed and Capitalized, Amount
   
Year ended December 31,
 
   
2025
   
2024
   
2023
 
                   
Cost of revenues
 
$
5,211
   
$
2,720
   
$
1,587
 
Research and development
   
6,243
     
11,221
     
13,690
 
Sales and marketing
   
790
     
1,228
     
1,409
 
General and administrative
   
3,710
     
4,513
     
5,634
 
 
                       
   
$
15,954
   
$
19,682
   
$
22,320